This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA

Dr. Dong-Eun Kim, PhD
Professor, Department of Bioscience and Biotechnology at Konkuk University
Speaker

Profile

Dong-Eun Kim is a Professor in the Department of Biosciences and Biotechnology at Konkuk University (Seoul, Korea) and the CEO of Uniwon PharmGene, Co. Ltd., a bio-startup specializing in RNA drug development. He earned his Ph.D. in Biochemistry from the Ohio State University and holds Master’s and Bachelor’s degrees in Chemistry from the Seoul National University. His research focuses on advanced biochemistry and innovative drug delivery systems, particularly RNA therapeutics and aptamers. Recently, his team introduced the Nicked Low dsRNA Template (NiLoT) strategy to improve the quality and safety of in vitro transcribed mRNA, a breakthrough featured in Nucleic Acids Research.

Agenda Sessions

  • Enhancing mRNA Translatability and Safety: Suppression of Antisense Transcription via the Nicked Low dsRNA Template (NiLoT) Strategy

    11:15am